I am a
Home I AM A Search Login

Papers of the Week

Papers: 11 Dec 2021 - 17 Dec 2021

Animal Studies, Pharmacology/Drug Development

2021 Dec 06


Enhanced ocular surface and intraoral nociception via a TRPV1 mechanism in a rat model of obstructive sleep apnea.


Kishimoto S, Katagiri A, Oyamaguchi A, Sato H, Toyoda H, Niwa H, Bereiter DA, Iwata K, Kato T
Neuroscience. 2021 Dec 06.
PMID: 34883200.


Obstructive sleep apnea (OSA), characterized by low arterial oxygen saturation during sleep, is associated with an increased risk of orofacial pain. In this study, we simulated chronic intermittent hypoxia (CIH) during the sleep/rest phase (light phase) to determine the role of transient receptor potential vanilloid 1 (TRPV1) in mediating enhanced orofacial nocifensive behavior and trigeminal spinal subnucleus caudalis (Vc) neuronal responses to capsaicin stimulation in a rat model of OSA. Rats were subjected to CIH (nadir O, 5%) during the light phase for 8 or 16 consecutive days. CIH yielded enhanced behavioral responses to capsaicin, a TRPV1 agonist, after application to the ocular surface and intraoral mucosa, which was reversed under normoxic conditions. The percentage of TRPV1-immunoreactive trigeminal ganglion neurons was greater in CIH rats than in normoxic rats and recovered under normoxic conditions after CIH. The ratio of large-sized TRPV1-immunoreactive trigeminal ganglion neurons increased in CIH rats. The density of TRPV1 positive primary afferent terminals in the superficial laminae of Vc was higher in CIH rats. The phosphorylated extracellular signal-regulated kinase (pERK)-immunoreactive cells intermingled with central terminal of TRPV1 positive afferents in the Vc. The number of pERK-immunoreactive cells following low-dose capsaicin (0.33 µM) application to the tongue was significantly greater in the middle portion of the Vc of CIH rats than in normoxic rats and recovered under normoxic conditions after CIH. These data suggest that CIH during the sleep (light) phase is sufficient to transiently enhance pain on the ocular surface and intraoral mucosa via TRPV1-dependent mechanisms.